ArticleScientific reports2020

Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma.

Jessica E Sagers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.